Table of Contents Table of Contents
Previous Page  2 / 8 Next Page
Information
Show Menu
Previous Page 2 / 8 Next Page
Page Background

Note:

Page 39

April 15-16, 2019 | Milan, Italy

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

alliedacademies.com

YEARS

Joint Event on

&

PUBLIC HEALTH,

EPIDEMIOLOGY AND NUTRITION

2

nd

World Congress on

CELL AND GENE THERAPY

2

nd

International Conference on

Cell and Gene Therapy 2019 & Public Health Congress 2019

Archives of General Internal Medicine | ISSN: 2591-7951 | Volume 3

NEW TOOLS FOR PURIFICATION AND IN-PROCESS ANALYSIS OF EXOSOMES

Ales Strancar

BIA Separations, Slovenia

E

xosomes bring a new set of challenges to purification and equally to in-process analysis. Some of those

challenges are in common with proteins, some are in common with virus particles, but many are unique to

exosomes. This leads to the conclusion that the traditional tool box needs to be extended. In this poster we

introduce a valuable new process tool and two new high through put in-process assay tools. Analytical results

from a new approach to exosome purification demonstrate the utility of all three..

Ales Strancar, Arch Gen Intern Med 2019, Volume 3 | DOI: 10.4066/2591-7951-C2-027

Ales Strancar is the CEO of BIA Separations and one of the main inventors of the CIM Convective Interaction Media® monolithic

columns (new generation of chromatographic support). He is author or co-author of more than 90 scientific papers dealing with

separation and purification technologies and is now one of top citied Slovenian scientists. He is a co-author of five granted USA pat-

ents and their foreign equivalents, more pending, in the field of biomolecule separations and purification. As well he is a co-author

of several book chapters dealing with novel chromatography technologies for biomolecule separation. He co-developed a number

of industrial scale purification processes among them for Octapharma, Vienna and for Boehringer Ingelheim, Vienna.

ales.strancar@biaseparations.com

BIOGRAPHY